Skip to main content

Want a detailed portfolio tracker?

Vir Biotechnology (VIR) P/E (2019 - 2026)

Vir Biotechnology (VIR) P/E from Oct 11, 2019 to Jul 21, 2026. The TTM Vir Biotechnology (VIR) P/E is -3.08. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Vir Biotechnology (VIR)

YearP/EChange
2026-3.08+61.15%
2025-1.91-0.55%
2024-1.92-14.43%
2023-2.25-176.85%
20222.92-71.94%
202110.41-196.14%
2020-10.83+29.84%
2019-8.34N/A

Comparison Vir Biotechnology (VIR) P/E with competitors

Vir Biotechnology (VIR) P/E is -3.08.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.14%
ENLVEnlivex Ltd0.07-102.43%
FGENFibroGen Inc0.24-107.80%
CHRSCoherus Biosciences Inc0.85-127.56%
FBIOFortress Biotech Inc0.95-130.82%
ORMPOramed Pharmaceuticals Inc1.50-148.82%
AGENAgenus Inc3.01-197.75%
INVAInnoviva Inc3.15-202.44%
VXRTVaxart Inc3.55-215.29%
CRMDCorMedix Inc3.63-217.85%
CVACCureVac N.V.4.45-244.39%
GLPGGalapagos NV4.86-257.81%
SRPTSarepta Therapeutics Inc4.88-258.57%
ABEOAbeona Therapeutics Inc5.39-274.98%
ABUSArbutus Biopharma Corp5.60-281.74%
ZVRAZevra Therapeutics Inc5.89-291.21%
SPROSpero Therapeutics Inc6.23-302.30%
CGENCompugen Ltd6.31-305.07%
RIGLRigel Pharmaceuticals6.87-323.20%
SLXNSilexion Therapeutics Corp7.30-336.97%
OMEROmeros Corporation9.26-400.72%
AUPHAurinia Pharmaceuticals Inc9.58-411.31%
PLXProtalix BioTherapeutics Inc10.89-453.73%
ACADAcadia Pharmaceuticals Inc11.73-480.94%
TBPHTheravance Biopharma Inc12.26-498.27%
ADMAAdma Biologics Inc12.42-503.34%
HRMYHarmony Biosciences Holdings Inc13.82-548.87%
SABSSAB Biotherapeutics Inc14.14-559.14%
NAGENiagen Bioscience Inc14.82-581.29%
INCYIncyte Corp15.82-613.91%
REGNRegeneron Pharmaceuticals Inc15.86-615.02%
PBYIPuma Biotechnology Inc17.32-662.41%
CPRXCatalyst Pharmaceuticals Inc17.44-666.42%
EXELExelixis Inc17.54-669.63%
TGTXTG Therapeutics Inc18.97-716.01%
MDXGMimedx Group Inc20.55-767.54%
XOMAXOMA Royalty Corp22.87-842.98%
ARGXArgen X SE24.30-889.21%
CTMXCytomX Therapeutics Inc24.82-906.20%
XOMAOXOMA Royalty Corp25.34-923.21%
HALOHalozyme Therapeutics Inc25.62-932.27%
XOMAPXOMA Royalty Corp25.67-933.78%
VRTXVertex Pharmaceuticals Inc27.99-1009.28%
RPRXRoyalty Pharma plc - Class A28.69-1031.78%
SLNOSoleno Therapeutics Inc29.02-1042.43%
ASNDAscendis Pharma A/S30.09-1077.19%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1331.40%
APLSApellis Pharmaceuticals Inc39.02-1367.43%
BMRNBiomarin Pharmaceutical Inc42.21-1471.06%
KRYSKrystal Biotech Inc45.34-1572.78%
ONCBeiGene Ltd69.54-2358.70%
PHARPharming Group N.V.75.03-2536.86%
TECHBio-Techne Corp101.96-3411.65%
VCELVericel Corp109.92-3670.29%
ALNYAlnylam Pharmaceuticals Inc117.96-3931.56%
GMABGenmab140.29-4656.71%
TLXTelix Pharmaceuticals Ltd162.15-5366.80%
CORTCorcept Therapeutics Inc212.86-7013.71%